Experimental Breast Cancer Drug

Published 04/07 2014 03:28PM

Updated 04/07 2014 03:29PM

An experimental drug shows promising results in treating advanced breast cancer. Researchers say in a study of 165 patients, the drug palbociclib, stopped tumors from growing a little more than 20 months. That's twice as long as the current treatment.

Patients who took palbociclib also took lived longer, but not by a significant amount. Those who received the drug lived about 37.5 months, compared with 33.3 months for those in the control group.

The drug is intended for patients with hormone receptor-positive, metastatic breast cancer.

Copyright 2016 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Featured Coupon


Featured Business